Drug · DIN 02437147
PRECEDEX
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 4, 2019; first marketed May 9, 2016.
- Drug Identification Number (DIN)
- 02437147
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Dexmedetomidine N05CM18
- Class
- Human
- Record last updated
- August 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE) | 4 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 7, 2018: NOC 20588New Drug Submission (NDS) · Merger - buyout
- February 16, 2015: NOC 16606Supplement to a New Drug Submission (SNDS) · New strength
Other DINs named PRECEDEX
- DIN 02339366 · Cancelled Post Market